Electrical stimuli relieve involuntary shaking
This article was originally published in Clinica
Executive Summary
Electrical stimulation of the brain can significantly relieve persistent shaking in conditions such as Parkinson's disease. Some 300 patients have been successfully treated in Europe since 1989, says Arzte Zeitung. The procedure, which is carried out under local anaesthetic, involves the insertion of an electrode into the brain. Correct positioning is established through X-ray and the electrode is then secured to the skull. A connecting wire is inserted under the skin leading to the pulse generator which is implanted pectorally. The stimuli affect the nerve centre which gives the signals for muscle tremors.
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.